Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
Victoria Wang, Robert J Gray, Fernanda I Arnaldez, James Zwiebel, Edith P Mitchell, Angela M DeMichele, Richard S Finn, Fangxin Hong, Amy S Clark, Lisa M McShane, Carlos L Arteaga, Keith T Flaherty, Alice P Chen, Lyndsay N Harris, Peter J O'Dwyer, Barbara A Conley, Ravneet Thind, Samer S Kasbari, Mehmet S Copur, Stanley R Hamilton, P Mickey Williams, David Patton, Larry V Rubinstein
Clinical cancer research : an official journal of the American Association for Cancer Research 2023;29(8):1477-1483